J&J appoint Ronald Williams to board
This article was originally published in Scrip
Johnson & Johnson has appointed Ronald Williams to its board of directors. Mr Williams previously served as chairman and CEO of Aetna and currently serves on President Obama's Management Advisory Board. At J&J he will serve on the Compensation & Benefits Committee and the Public Policy Advisory Committee of the board.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.